PMC:7405836 / 93250-93499 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T328","span":{"begin":182,"end":185},"obj":"Body_part"}],"attributes":[{"id":"A328","pred":"fma_id","subj":"T328","obj":"http://purl.org/sig/ont/fma/fma74412"}],"text":" for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. CEPI and the "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T867","span":{"begin":85,"end":93},"obj":"Disease"},{"id":"T868","span":{"begin":85,"end":89},"obj":"Disease"}],"attributes":[{"id":"A867","pred":"mondo_id","subj":"T867","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A868","pred":"mondo_id","subj":"T868","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. CEPI and the "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T853","span":{"begin":46,"end":49},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T854","span":{"begin":106,"end":109},"obj":"http://purl.obolibrary.org/obo/CLO_0054057"},{"id":"T855","span":{"begin":117,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T856","span":{"begin":121,"end":122},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T857","span":{"begin":171,"end":172},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. CEPI and the "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T47845","span":{"begin":182,"end":185},"obj":"Chemical"}],"attributes":[{"id":"A75901","pred":"chebi_id","subj":"T47845","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"}],"text":" for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. CEPI and the "}

{"project":"LitCovid-sentences","denotations":[{"id":"T650","span":{"begin":112,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. CEPI and the "}

{"project":"LitCovid-PubTator","denotations":[{"id":"2553","span":{"begin":85,"end":95},"obj":"Species"},{"id":"2554","span":{"begin":173,"end":181},"obj":"Species"}],"attributes":[{"id":"A2553","pred":"tao:has_database_id","subj":"2553","obj":"Tax:2697049"},{"id":"A2554","pred":"tao:has_database_id","subj":"2554","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. CEPI and the "}